Big Board

Content Ideas
Result Content Idea Research
Result Content Idea Research
1 Partial Response or Better Associated With Prolonged PFS With Ibrutinib in WM
2 Enzalutamide Yields PFS Benefit Across nmCRPC Subgroups
3 Ibrutinib Plus Rituximab Prolongs PFS, Leads to Sustained Hemoglobin Improvements in Patients with Waldenstrom Macroglobulinemia
4 B-DRC Produces Deep Remissions, Clinically Meaningful PFS Rates in Patients with Waldenstrom Macroglobulinemia
5 Provident Financial Services Inc (PFS) Soars 4.38% on December 04
6 Acalabrutinib Improves PFS and OS Over Other First-Line Regimens in CLL
7 Umbralisib Plus Ublituximab Prolongs PFS in Treatment-Naïve, Relapsed/Refractory CLL
8 SOLAR-1: OS data support PFS findings for fulvestrant plus alpelisib
9 Provident Strengthens Retail Banking Leadership Team with Key Appointments
10 Mining Weekly SolGold delays Alpala PFS to 2021
11 Global Polymeric Ferric Sulfate(Pfs) Market Report 2020 to Talk about Historical Development and Estimated Forecast 2026
12 How Emergency Medicine Physicians Can Increase Revenue in 2021 with Medicare PFS Cuts Looming
13 First-Line Lorlatinib Improves PFS in ALK-Positive NSCLC
14 MMIH appoints Pinnacle Pathways for PFS
15 Why Provident Financial (PFS) Stock Might be a Great Pick
16 Personalized vaccine improves PFS in newly diagnosed glioblastoma
17 Small PFS Bump With XPO1 Inhibitor for Dedifferentiated Liposarcoma
18 Maintenance ixazomib extends PFS for subset of patients with multiple myeloma
19 Selinexor Improves PFS in Advanced Unresectable Dedifferentiated Liposarcoma
20 Misima project PFS delivers strong pre-tax NPV of A$822m and 33% IRR
21 Olaparib Leads to Increased Survival for Patients with Metastatic Castration-Resistant Prostate Cancer
22 Cancer Vaccine AV-GBM-1 Improves PFS in Newly Diagnosed Glioblastoma
23 Keytruda + Lenvima meet PFS primary endpoint in advanced RCC
24 Ripretinib Given as Intra-Patient Dose Escalation Shows Clinically Meaningful PFS in GIST After Disease Progression
25 Rafaella Resources (ASX:RFR) releases PFS for Santa Comba Project
26 Final Policy, Payment, and Quality Provisions Changes to the Medicare Physician Fee Schedule for Calendar Year 2021: SF STAT!
27 Sugemalimab/Chemo Combo Elicits Clinically Meaningful PFS Benefit in Metastatic NSCLC
28 Three-Drug Regimen Reduces Myeloma Treatment Burden
29 CMS final 2021 physician fee schedule rule
30 US Gold Corp. provide PFS update
31 SolGold's Alpala PFS release date moved back
32 Proposed CMS Cuts And the Future of Surgical Education
33 Lorlatinib extends PFS vs. crizotinib as first-line treatment in ALK -positive NSCLC
34 GoviEx Provides Status Report on Madaouela Updated PFS and Updates on Falea Polymetallic Exploration Program Underway
35 Integra Engages Mine Development Associates as Lead Engineering Firm to Manage the DeLamar Project 2021 Pre-Feasibility Study and Announces Recent Appointments
36 Element 25"s updated Butcherbird PFS highlights robust returns even at conservative manganese prices
37 SolGold delays Alpala PFS again to early 2021
38 Mining Weekly Misima PFS proves up
39 Pembrolizumab 'Preferred Choice' in MSI-H/dMMR Metastatic CRC
40 Maintenance Niraparib, Given at Individualized Starting Dose, Improves PFS in Chinese Patients With Ovarian Cancer
41 Former PFS president joins Plan Works
42 Year in Review: Multiple Myeloma
43 Provident Financial Services, Inc (PFS) Ex-Dividend Date Scheduled for November 12, 2020
44 Venclexta With Velcade and Dexamethasone May Improve Progression-Free Survival in Relapsed or Refractory Multiple Myeloma
45 Year in Review: Triple-Negative Breast Cancer
46 Analysts Expect Provident Financial Services, Inc. (NYSE:PFS) Will Announce Quarterly Sales of $105.73 Million
47 Provident Financial Services, Inc. (NYSE:PFS) Sees Large Decrease in Short Interest
48 KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Demonstrated Statistically Significant Improvement in Progression-Free Survival (PFS), Overall Survival (OS) and Objective Response Rate (ORR) Versus Sunitinib as First-Line Treatment for Patients…
49 Will the vaccines be in Prefilled Syringes?
50 Bone Metastases in mRCC May Not Portend Worse Prognosis
51 Palbociclib Demonstrates Prolonged OS/PFS When Initiated in Metastatic Breast Cancer
52 Sintilimab/Bevacizumab Biosimilar Combo Shows Superior OS, PFS Over Sorafenib in Advanced Unresectable HCC
53 PFSweb Opens Dallas Area Fulfillment Center to Support Kendra Scott's eCommerce Program
54 MITA voices opposition to deep healthcare cuts included in the Physician Fee Schedule (PFS) Final Rule for CY 2021
55 How Do Age and Fitness Impact Venetoclax Efficacy in Patients with CLL?
56 BD to Invest $1.2 Billion Over Four Years in Pre-Fillable Syringe, or PFS, Manufacturing Capacity
57 Should Income Investors Look At Provident Financial Services, Inc. (NYSE:PFS) Before Its Ex-Dividend?
58 Polymeric Ferric Sulfate(PFS) Market Business Status, Industry Trends and Outlook 2020 to 2025
59 Global Industrial Level Polymeric Ferric Sulfate (PFS) Market Overview, Development History and Forecast to 2026 shared in Latest Research
60 Cypress Development Studies Chloride Leaching for Clayton Valley Lithium Project in Nevada
61 New Data for TecartusTM Demonstrate Durable Responses at One Year Follow-Up in Relapsed or Refractory Mantle Cell Lymphoma
62 Updated PFS extends Dougou Extension project's life-of-mine to 30 years
63 Active Surveillance a Safe Strategy for Patients with Small Renal Masses Suspicious for RCC
64 Paradigm-Changing Study Results for MSI-H Metastatic CRC
65 Single-Agent Ibrutinib Leads to Durable Responses in Relapsed/Refractory MZL
66 PFSweb Inc. (PFSW) Soars 2.66% on December 04
67 14 Year-End Tax and Financial Tips
68 Drive-in Screening of 'Polar Express' Free with Food Donation
69 Four-Factor CLL Prognostic Score Deemed Clinically Useful for Risk Classification
70 MetalNRG says to redo Imwelo PFS and scoping study when acquisition of Lake Victoria Gold completes
71 Global Polymeric Ferric Sulfate (PFS) Market Size 2020: Industry Size, Share, Future Challenges, Revenue, ...
72 Safety and clinical efficacy of BCMA CAR-T-cell therapy in multiple myeloma
73 Once-Per-Week Selinexor Triplet Appears Effective in Patients With Multiple Myeloma
74 Clinical implications of germline BCL2L11 deletion polymorphism in pretreated advanced NSCLC patients with osimertinib therapy
75 Novel Approaches Challenge Toxicity Restraints in Classical Hodgkin Lymphoma
76 Lenvatinib in Combination with Pembrolizumab or Everolimus Shows Promise for Advanced RCC
77 Gene Mutations and Transcriptional Signatures Correlate With Response to Therapy in Advanced Renal Cell Carcinoma
78 ATLANTIS Trial Misses Primary End Point in Patients With SCLC
79 PFS Rubber Stopper Market 2019 | Analyzing The Impact Followed By Restraints, Opportunities And Projected Developments | DataIntelo
80 Evaluation of EuroFlow minimal residual disease measurement and donor chimerism monitoring following tandem auto-allogeneic transplantation for multiple myeloma
81 Delaying BCG immunotherapy onset after transurethral resection of non-muscle-invasive bladder cancer is ass...
82 Promising KGL PFS to lead into BFS
83 New Dose Strategy for Ceritinib May Improve Outcomes in ALK-Positive NSCLC
84 Admission to drive-in screening of 'Polar Express' free with canned food donation
85 PFS welcomes adviser increase but warns on future
86 Boston Celtics: 3 trade packages for traditional power forwards
87 Form 6-K Integra Resources Corp. For: Dec 03
88 BLA Submitted for Amivantamab as Treatment of Metastatic NSCLC With EGFR Exon 20 Insertion
89 Provident Financial Services (NYSE:PFS) Upgraded to "B-" by TheStreet
90 Gold majors spell out LatAm priorities
91 Provident Financial Services, Inc. (NYSE:PFS) Given Average Rating of "Hold" by Analysts
92 Ex-PFS president Owen joins paraplanning firm as non-exec
93 Nearly 40% of PFS members hit by reduction in new clients
94 In APOLLO, Subcutaneous Daratumumab With Pomalidomide Cuts Progression, Death Risk 37% in Relapsed MM
95 Chemo-Free Ibrutinib and Rituximab Show Promising Activity in Older Patients with MCL
96 Study Shows Significant Improvements Since 1984 in Survival Rates After Allogeneic Transplantation
97 These Factors Predict Early Progression Following CAR-T Therapy in DLBCL
98 Foran Mining Corporation Announces Closing of Private Placement
99 Polymeric Ferric Sulfate(PFS) China Market 2020 and Forecast 2021-2027
100 Permian Frac Sand LLC (PFS) continues to thrive while the industry shrinks amid a pandemic